GHIT Fund Advancing Portfolio

As of 2017.10.31

DRUG DEVELOPMENT

VACCINE DEVELOPMENT

DIAGNOSTIC DEVELOPMENT

PORTOFOLIO

m1_1 m1_2 m1_3 m1_4 m2_1 m2_2 m2_3 m2_4 m2_5 m2_6 m2_7 m2_8 m2_9 m2_10 m2_11 m3_1 m3_2 m3_3 m3_4 m3_5 m3_6 m3_7 m4_1 m4_2 m4_3 m4_4 m4_5 m4_6 m4_7 m4_8 m4_9 m4_10 m4_11 m5_1 m5_2 m5_3 m5_4 m5_5 m5_6 m5_7 m5_8 m5_9 t1_1 t1_2 t2_1 t2_2 t2_3 t2_4 t2_5 t2_6 t2_7 t2_8 t2_9 t2_10 t3_1 t3_2 t4_1 t4_2 t4_3 t5_1 n1_1 n2_1 n2_2 n2_3 n2_4 n2_5 n3_1 n3_2 n3_3 n4_1 n4_2 n4_3 n4_4 n4_5 n4_6 n4_7 n4_8 n4_9 n4_10 n4_11 n4_12 n4_13 n4_14 n5_1 n5_2 n5_3 n5_4 n5_5 m1_1 m1_2 m3_3 m2_1 m2_2 m2_3 m3_1 m3_2 m3_3 m4_1 m4_2 m4_3 m4_4 m4_5 m4_6 m5_1 m5_2 m5_3 m5_4 t1_1 t1_2 t2_1 t2_2 t2_3 t2_4 t3_1 t3_2 t4_1 t5_1 n1_1 n2_1 n2_2 n2_3 n3_1 n3_2 n4_1 n4_2 n4_3 n4_4 n4_5 n4_7 n4_8 n4_6 n5_1 n5_2 n5_3
*Disclaimer: The awarded amount refers to the conditional investment figure agreed at the initiation of each project.
As of 2017.10.31